ADMAADMA BIOLOGICS, INC.vs its industry peers
A metric-by-metric comparison of ADMA BIOLOGICS, INC. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADMAEsta | $2.6B#2 | 16.3x#1 | 6.3x#7 | 5.0x#2 | 19.6%#4 | -25.7%#4 | 37.5%#2 | 36.0%#1 | 32.9%#1 | 5#2 | — | — |
| BEAM | $2.8B#1 | — | 2.6x#3 | 20.1x#5 | 120.0%#1 | 78.8%#2 | -274.6%#5 | -7.5%#4 | -40.5%#3 | — | 14.4%#2 | — |
| RVMDW | $2.2B#3 | — | 0.8x#1 | — | — | -88.5%#7 | — | -43.4%#6 | — | — | 2467.8%#1 | — |
| BCRX | $2.2B#4 | — | — | 2.5x#1 | 94.1%#2 | 396.9%#1 | 39.0%#1 | — | — | — | — | — |
| RXRX | $2.2B#5 | — | 2.4x#2 | 28.9x#6 | 26.9%#3 | -39.1%#6 | -867.9%#6 | -70.5%#7 | -175.2%#5 | — | — | — |
| VCEL | $2.1B#6 | 83.8x#2 | 5.6x#6 | 7.5x#3 | 16.5%#5 | 59.4%#3 | 4.0%#3 | 4.5%#2 | 4.0%#2 | 7#1 | — | — |
| COAG | $1.9B#7 | — | 4.3x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| MAZE | $1.7B#8 | — | 3.9x#4 | 10.4x#4 | — | -351.0%#8 | -85.3%#4 | -28.9%#5 | -49.4%#4 | — | — | — |
| REPL | $1.7B#9 | — | 8.1x#8 | — | — | -26.9%#5 | — | -153.3%#8 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice